Unsupervised cardiometabolic phenotyping unmasks residual MACCE risk beyond LDL-C in acute myocardial infarction after revascularization. [PDF]
Xu W +8 more
europepmc +1 more source
Early Inflammatory Biomarkers, Ventricular Dysfunction and In-Hospital Mortality in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. [PDF]
Magureanu DC +4 more
europepmc +1 more source
Specificity of the Occlusion Myocardial Infarction-Trained PMcardio "Queen of Hearts" AI-ECG in Inflammatory Myopericardial Syndromes. [PDF]
Bennar W +8 more
europepmc +1 more source
Catastrophic multisystem arterial thromboembolism masked by acute ST-elevation myocardial infarction and cardiogenic shock in a rheumatic mitral stenosis patient: a case report. [PDF]
Tran QQ, Dang DV, Do CV.
europepmc +1 more source
Non‐ST‐elevated myocardial infarction with “N” wave on electrocardiogram and culprit vessel in left circumflex has a risk equivalent to ST‐elevated myocardial infarction [PDF]
Peng Fu
exaly +2 more sources
Related searches:
Myocardial Bridging in a Man With Non–ST-Elevation Myocardial Infarction
Circulation, 2015A 75-year-old man with hyperlipidemia was admitted with substernal chest tightness associated with an elevated cardiac-specific troponin. He had experienced symptoms of an upper respiratory tract infection with fever, cough, and decreased oral intake over the previous 2 weeks.
Brian A, Bergmark +3 more
openaire +2 more sources
Management of non–ST-Segment Elevation Myocardial Infarction
Medical Clinics of North America, 2007Non-ST-segment elevation myocardial infarction (NSTEMI) is a major cause of cardiovascular morbidity and mortality in the United States. It represents the highest risk category of non-ST-segment elevation acute coronary syndromes (NSTEACS), for which timely diagnosis and appropriate therapy are paramount to improve outcomes.
Stephen E, Van Horn, Calin V, Maniu
openaire +2 more sources

